Inspiring talks, discussions and interviews – Park Annual gives you the opportunity to listen to interesting leaders, entrepreneurs and experts.
Leif is Chairman of the Board of Directors of AstraZeneca and holds board positions at Autoliv, Inc and Ecolean AB. He has been a member of the Royal Swedish Academy of Engineering Sciences since 1994 (Chairman 2012-2017). Leif is also a member of the European Round Table of Industrialists (Chairman 2009-2014) and a Member of the Council of Advisors, Boao Forum for Asia.
1997-2011, Leif was Chief Executive Officer of AB Volvo. Prior to that, he served at AB Electrolux, latterly as Chief Executive Officer 1994-1997. He was a Non-Executive Director of BMS from1998 to Sep 2011, serving on the Board’s Audit Committee, and Compensation and Management Development Committee. Leif was Chairman of global telecommunications company, LM Ericsson, from 2011 to March 2018. He holds an MSc in engineering from Chalmers University of Technology, Gothenburg.
An internationally respected scientist who has published more than 700 scientific articles that have been cited more than 70,000 times. He has received the Novozymes Prize, the ENI Prize, the Eric and Sheila Samson Prime Ministers Prize for Innovation in Alternative Fuels for Transportation, Nature Award for Mentoring, the Emil Chr. Hansen Prize, and the Gold Medal from the Royal Swedish Academy of Engineering Sciences. In 2019 he was honored as Knight, Ridder af Dannebrog, from Her Majesty The Queen of Denmark, for his meritorious service and contribution to science.
Jens has several years of entrepreneurial expertise as the founder of companies such as Fluxome, MycoTeQ, MetaboGen, Biopetrolia and Elypta. In 2019 he was awarded the Arvid Carlsson Award by Sahlgrenska SP.
Elected into the Royal Swedish Academy of Sciences, the Royal Danish Academy of Science and Letters, the National Academy of Sciences (USA) and the National Academy of Engineering (USA).
Marianne has extensive experience in strategic management of life science companies.
She previously held the position as CEO of Kronans Droghandel, The sixth AP fund, Global Health Partner and deputy CEO of Apoteket AB.
Other assignments at present: Chairman of the board of Saminvest. Board member of Recipharm AB (publ), Enzymatica AB (publ), Praktikertjänst Aktiebolag, Promore Pharma AB and Council member of Skandia. Chairman of the Royal Swedish Academy of Engineering Sciences (IVA) west section.
Magnus Lindkvist is driven by a relentless curiosity about our mental space where the outside world collides with the human brain. His book Minifesto tells us why small ideas matter in the world of grand narratives.
He has a Master of Science in Business and Economics from Stockholm School of Economics and a degree in film production from UCLA.
His talks are often described as ‘shows’ or ‘performances’; he calls it ‘intellectual acupuncture’ with the expressed intention of changing our minds with needles of insight, examples and observations.
He has won several awards for his ‘performances’ on stage and for his books, but perhaps the best acclaim ever given was from an HR director in the UK who said ‘Magnus Lindkvist is the best Swedish export since ABBA and meatballs.’
Charlotta has extensive experience in managing companies and projects within the health and healthcare industry, and has previously held leading positions in the pharmaceutical industry such as GlaxoSmithKline and Astellas Pharma. She has also been responsible for investment management in early stage growth companies within life tech at Almi Invest.
Charlotta is member of the European Union MedTech Partnership Group, the International Association of Science Parks, Supervisory Council of Svenska Mässan and the Board of Connect Sweden West. She is also member of the Jury of Nordic ehealthAward.
Charlotta has basic medical traning as a registered nurse and has studied business and administration and leadership.
Mattias Perjos is the President and CEO of Getinge, a global leading supplier of innovative medtech products and solutions within healthcare and life science.
Prior to his current position Mattias held the position as CEO of the IPS Division in the Coesia Group, a privately owned Italian group of companies. In addition to his role as CEO, Mattias was Managing Director of Coesia International which includes the subsidiaries in China, Japan, South Korea, South-East Asia, India, the Americas, Russia, Africa and the Middle East.
Mattias began his career at Sandvik and shortly thereafter joined FlexLink, where he held a number of leading international positions between the years 1997 and 2012 including the role of CEO from 2006.
Mattias was born in 1972 and holds a Master of Science in Industrial Engineering and Management from Luleå University of Technology.
Johannes is an engineer and entrepreneur who has been part of founding innovative tech-companies toward different industries.
Over the years he has taken special interest in the decision making process and spent five years as an independent consultant helping to improve decision making in big pharma. In 2012 Johannes co-founded Captario AB with the mission to create a positive step change to the pharma industry.
Today, Captario works with many of the world’s largest pharma companies. Its SaaS enterprise solution uses AI-driven modeling and simulation to enable a robust and rapid decision making in both drug development projects and portfolios.
Louise Warme is a Medical Doctor and investor who has acquired several years of strategic, leadership, and board member experience, especially in life science startups through ALMI Invest, Aqilion and LARA Diagnostics.
She now serves as an Investment Manager at ALMI Invest and as a member of the board at Life Genomics, Amferia and Inorbit Therapeutics among others.
Anand is a scientist and entrepreneur who is driven to bring new life-science technologies for improving human health. Anand holds a PhD in Materials Science from Chalmers University of Technology and is the inventor of the material platform serving Amferia’s healthcare technology.
Anand is the inventor of two patents and has published in high impact scientific journals such as Advanced Materials and Nature Communications. Today, he leads Amferia’s business and technical development portfolio.
Dr Bo Norrman works as Innovation Advisor at Chalmers University of Technology and is also senior advisor to the Chalmers Health Engineering Area of Advance. He has a long background working with Life Science development in the Västra Götaland region and has been actively involved in Medtech West since its start.
Previously, Bo has worked with academic research in medical biochemistry, microbiology and bioprocess development. He has been the CTO of a SME working with medical diagnostics and has worked at Karolinska Institute Unit for Bioentrepreneurship, where he worked with starting Karolinskas Master programme in bioentrepreneurship.
Currently, he is also working as an advisor in regional development strategy to the Västra Götaland region.
A senior executive with an extensive network and experience in life science and innovation. As VP Health and Life Science, her role is to identify and launch strategic initiatives to support the transformation of Swedish healthcare and the development of the Swedish Life science industry.
In the Life Science industry she has held several global positions in strategic marketing and business development in companies such as Ferring Pharmaceuticals and Coloplast. Since 2009, Sylvie has focused her attention on the interface between academia, public-private partnerships and industry collaborations. She has developed an innovation platform at Lund University, and also contributed to the creation of the Copenhagen Healthtech Cluster. From Sep 2015 to Jan 2018, she lead the development of EIT Health into the successful Knowledge and Innovation Community it is today, as its CEO.
Sylvie has a B.Sc. in Economics and Business Administration from Uppsala University and an Executive MBA from CBS-SIMI. She has a Master in Coaching and is supporting startups as a coach and mentor.
Dr Paul Tunnah founded pharmaphorum in 2009, which combines industry leading publications (www.pharmaphorum.com) strategic consulting and a content-driven stakeholder engagement agency (www.pharmaphorumconnect.com).
He is a recognised author, speaker and industry advisor with a passion for helping organisations tell authentic stories that resonate, co-create solutions and unlock the power of digital and social media in connecting with customers and understanding markets.
In June 2020, he became Chief Content Officer for Healthware Group (www.healthwaregroup.com), a next-generation integrated consulting group that operates at the intersection of the transformation of commercial operations and digital health, offering a unique range of services combining design, strategy, communication and innovation with technology and corporate venturing.
Dr Tunnah holds a BA in Biochemistry and DPhil in Biological Sciences from Oxford University.
Megan Coder is Executive Director of the Digital Therapeutics Alliance (DTA), an international non-profit trade association of industry leaders and stakeholders dedicated to improving clinical and health economic outcomes through the use of high quality, evidence-based digital therapeutics. DTA’s membership spans 15 countries across four major healthcare industries.
Trained as a pharmacist, Megan graduated from the University of Wisconsin—Madison and completed an Executive Residency in Association Management & Leadership with the American Pharmacists Association Foundation. Prior to joining DTA, Megan worked with Voluntis, Iodine, the Pharmaceutical Care Management Association, and the Pharmacy Technician Certification Board.
Conor leads a team of marketers along the wire between being new and exciting, while ensuring consistency and stability for customers in the life sciences industry. His career in marketing, communications and public affairs spans more than 18 years. Conor has served as Chief Communications Officer and Head of Public Affairs for GE Healthcare Life Sciences since 2012. His grasp of the industry’s priorities earned him an appointment in 2014 as director and trustee of CaSE, the UK Campaign for Science and Engineering, where he still serves.
Born in Zaire, Conor has lived and worked in Africa, the Netherlands, Brazil, Indonesia, Saudi Arabia, Italy, Sweden and the UK. He has an MA in Philosophy, Psychology and Business from the Universities of Glasgow and University of California Santa Barbara, where his 1996 MA thesis focused on the ethics of virtual reality and emerging technologies.
Having close family and friends who’ve suffered from mental health challenges and dementia, Rich experienced first-hand the challenge of accessing support for both those affected by the illness and the families involved. In 2013, he founded Healios to tackle the global inequality of healthcare provision affecting over one billion people worldwide with mental health and neurodevelopmental conditions by combining science, clinical expertise and design with cutting edge technology.
His passion for improving lives by bringing exceptional healthcare services that fit around the lifestyles and circumstance of the whole family has led him to develop world-leading innovations. Rich pioneered the digitalisation of entire clinical outpatient pathways covering a range of complex specialist assessments and psychological interventions for children and adults in mental health, autism and ADHD.
Rich is a Board member of Mental Health Network at the UK’s NHS Confederation and healthcare advisor to The Economist.
24 years (and counting) at Volvo Cars, of which 19 with Protective Safety focus and 3 at Volvo Cars of North America in Rockleigh, NJ, USA.
In recent years Pär has helped develop the world first Run Off Road protection package and SRS Large Animal detection (launched in the Volvo XC90 in 2015). These days he pushes the Safety boundaries and development within Digital Health.
In the past he has worked on all aspects of SRS sensor systems, from AE to product development (starting with the P1X SRS sensor system, launched in the Volvo V40 in 2003) to field cases and quality follow-up, as well as occupant/interior sensors and advanced eCall systems.
Dr Magnus Björsne graduated at the University of Lund in 1989 and took his post graduate studies at Stockholm University where he did his PhD in Medicinal Chemistry.
He joined AstraZeneca in 1995 and has held a series of managerial positions within Cardiovascular Research Management. Magnus moved to the Strategic Planning & Business Development organization in 2006 where he has been leading the Cardiovascular Business Development team involved in the search, evaluation and transaction of M&As and licensing deals. In 2014 he implemented AZ BioVentureHub – a novel approach to open innovation which has received multiple international rewards. It allows Biotechs and academic groups cross different industry segments to work in close proximity to the skills and capabilities that resides within big pharma. Magnus is the AZ board member of SwedenBio and is a member of the Advisory Board of RISE.
Mia has a background in journalism and strategic communication. Her dedication to meaningful communication that makes a difference has given her 20 years of experience of strategic and hands-on communication work, mainly within Life Science. She has held various positions in AstraZeneca’s Global Corporate Affairs organisation, most recently as Global Science Communications Director showcasing early R&D efforts with a focus on digital channels and major scientific events. Mia also ran her own communications consultancy for many years, often supporting Life Science entrepreneurs and the start-up scene.
She has a broad network in Life Science, and in the role as Head of Communication at Sahlgrenska Science Park, Mia leads the regional work with strengthening and positioning of the West Swedish Life Science cluster.
At Park Annual 2020, Mia is one of the main moderators during the day.
Magnus is an innovation management professional with 15+ years of experience in the field. He holds a PhD in innovation management and is an appreciated speaker and facilitator. Magnus has previously led cross-continental teams and projects focusing on innovation and change management and has driven large initiatives on open innovation and innovation ecosystems. His curiosity has led to five patents and he is continuously looking for opportunities to learn from others.
At Park Annual 2020, Magnus is one of the main moderators during the day.